205 related articles for article (PubMed ID: 15470083)
1. Protein kinase C and epidermal growth factor stimulation of Raf1 potentiates adenylyl cyclase type 6 activation in intact cells.
Beazely MA; Alan JK; Watts VJ
Mol Pharmacol; 2005 Jan; 67(1):250-9. PubMed ID: 15470083
[TBL] [Abstract][Full Text] [Related]
2. Activation of a novel PKC isoform synergistically enhances D2L dopamine receptor-mediated sensitization of adenylate cyclase type 6.
Beazely MA; Watts VJ
Cell Signal; 2005 May; 17(5):647-53. PubMed ID: 15683739
[TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the potential phosphorylation sites for protein kinase C on the CCK(A) receptor.
Smeets RL; Fouraux MA; Pouwels W; van Emst-de Vries SE; Ronken E; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Jul; 124(5):935-45. PubMed ID: 9692779
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II type 1 receptor signals through Raf-1 by a protein kinase C-dependent, Ras-independent mechanism.
Arai H; Escobedo JA
Mol Pharmacol; 1996 Sep; 50(3):522-8. PubMed ID: 8794890
[TBL] [Abstract][Full Text] [Related]
5. Galphaq-coupled receptor signaling enhances adenylate cyclase type 6 activation.
Beazely MA; Watts VJ
Biochem Pharmacol; 2005 Jul; 70(1):113-20. PubMed ID: 15885660
[TBL] [Abstract][Full Text] [Related]
6. Adenylyl cyclase isoform-selective regulation of vascular smooth muscle proliferation and cytoskeletal reorganization.
Gros R; Ding Q; Chorazyczewski J; Pickering JG; Limbird LE; Feldman RD
Circ Res; 2006 Oct; 99(8):845-52. PubMed ID: 16973907
[TBL] [Abstract][Full Text] [Related]
7. Multiple phosphorylation sites are required for pathway-selective uncoupling of the 5-hydroxytryptamine1A receptor by protein kinase C.
Lembo PM; Albert PR
Mol Pharmacol; 1995 Dec; 48(6):1024-9. PubMed ID: 8848001
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C activators sensitize cyclic AMP accumulation by intact 1321N1 human astrocytoma cells.
Johnson RA; Toews ML
Mol Pharmacol; 1990 Feb; 37(2):296-303. PubMed ID: 1689454
[TBL] [Abstract][Full Text] [Related]
9. Dexamethasone-induced Ras protein 1 negatively regulates protein kinase C delta: implications for adenylyl cyclase 2 signaling.
Nguyen CH; Watts VJ
Mol Pharmacol; 2006 May; 69(5):1763-71. PubMed ID: 16489124
[TBL] [Abstract][Full Text] [Related]
10. Adenylyl cyclase-cAMP system inhibits thrombin-induced HSP27 in vascular smooth muscle cells.
Hirade K; Tanabe K; Niwa M; Ishisaki A; Nakajima K; Nakamura M; Sugiyama T; Katagiri Y; Kato K; Kozawa O
J Cell Biochem; 2005 Feb; 94(3):573-84. PubMed ID: 15543559
[TBL] [Abstract][Full Text] [Related]
11. Thrombin and phorbol esters potentiate Gs-mediated cAMP formation in intact human erythroid progenitors via two synergistic signaling pathways converging on adenylyl cyclase type VII.
Haslauer M; Baltensperger K; Porzig H
Mol Pharmacol; 1998 May; 53(5):837-45. PubMed ID: 9584209
[TBL] [Abstract][Full Text] [Related]
12. Activators of protein kinase C but not of phospholipase C modulate adenylate cyclase-responses of normal pig epidermis.
Iizuka H; Takahashi H; Ishida-Yamamoto A; Hashimoto Y
Epithelial Cell Biol; 1995; 4(1):35-41. PubMed ID: 8563794
[TBL] [Abstract][Full Text] [Related]
13. Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A.
Chern Y; Chiou JY; Lai HL; Tsai MH
Mol Pharmacol; 1995 Jul; 48(1):1-8. PubMed ID: 7623763
[TBL] [Abstract][Full Text] [Related]
14. Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors.
Cumbay MG; Watts VJ
J Pharmacol Exp Ther; 2001 Jun; 297(3):1201-9. PubMed ID: 11356947
[TBL] [Abstract][Full Text] [Related]
15. Converging protein kinase pathways mediate adenylyl cyclase superactivation upon chronic delta-opioid agonist treatment.
Varga EV; Rubenzik MK; Stropova D; Sugiyama M; Grife V; Hruby VJ; Rice KC; Roeske WR; Yamamura HI
J Pharmacol Exp Ther; 2003 Jul; 306(1):109-15. PubMed ID: 12660310
[TBL] [Abstract][Full Text] [Related]
16. Identification of protein kinase C phosphorylation sites in the angiotensin II (AT1A) receptor.
Qian H; Pipolo L; Thomas WG
Biochem J; 1999 Nov; 343 Pt 3(Pt 3):637-44. PubMed ID: 10527943
[TBL] [Abstract][Full Text] [Related]
17. Protein kinase C-mediated inhibition of transmembrane signalling through CCK(A) and CCK(B) receptors.
Smeets RL; Fouraux MA; van Emst-de Vries SE; De Pont JJ; Willems PH
Br J Pharmacol; 1998 Mar; 123(6):1189-97. PubMed ID: 9559904
[TBL] [Abstract][Full Text] [Related]
18. Protein kinase C regulates the activity and stability of serotonin N-acetyltransferase.
Choi BH; Chae HD; Park TJ; Oh J; Lim J; Kang SS; Ha H; Kim KT
J Neurochem; 2004 Jul; 90(2):442-54. PubMed ID: 15228600
[TBL] [Abstract][Full Text] [Related]
19. Differential responses of corticotropin-releasing hormone receptor type 1 variants to protein kinase C phosphorylation.
Markovic D; Papadopoulou N; Teli T; Randeva H; Levine MA; Hillhouse EW; Grammatopoulos DK
J Pharmacol Exp Ther; 2006 Dec; 319(3):1032-42. PubMed ID: 16956982
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C-epsilon associates with the Raf-1 kinase and induces the production of growth factors that stimulate Raf-1 activity.
Ueffing M; Lovrić J; Philipp A; Mischak H; Kolch W
Oncogene; 1997 Dec; 15(24):2921-7. PubMed ID: 9416835
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
